The Drug Policy Alliance (DPA) is a prominent advocacy group that champions the reform of drug laws in the United States, with a particular emphasis on cannabis policy. Established in 2000 through the unification of The Lindesmith Center and the Drug Policy Foundation, the DPA has been instrumental in shaping progressive drug policies that prioritize public health and human rights. The organization’s efforts have significantly contributed to the shift in public perception and legislation regarding cannabis, advocating for its decriminalization and responsible regulation. Over time, the Drug Policy Alliance has expanded its focus to include issues such as racial equity, harm reduction, and the dismantling of punitive drug laws that disproportionately affect marginalized communities. By leveraging research and advocacy, the DPA continues to lead the charge in transforming drug policy to reflect modern values and scientific insights. To learn more about their initiatives, visit [drugpolicy.org](https://www.drugpolicy.org).
The Drug Policy Alliance (DPA) is a New York City–based nonprofit organization that seeks to advance policies that "reduce the harms of both drug use and drug prohibition, and to promote the sovereignty of individuals over their minds and bodies". The organization prioritizes reducing the role of criminalization in drug policy, advocating for the legal regulation of marijuana, and promoting health-centered drug policies.
 | |
| |
| Established | 2000  (26 years ago) |
|---|---|
| Legal status | 501(c)(3) organization |
| Headquarters | New York City |
| Country | United States |
| Revenue | 10,430,244 United States dollar (2016) |
| Total Assets | 13,012,787 United States dollar (2020) |
| Website | www |